GAM Holding’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

GAM Holding’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18,800	Closed	-$1.79M	–	547
2019 Q4	$1.79M	Hold	18,800	–	–	0.08%	241
2019 Q3	$1.43M	Hold	18,800	–	–	0.06%	307
2019 Q2	$1.65M	Sell	18,800 -500	-3%	-$42.6K	0.06%	330
2019 Q1	$1.75M	Buy	19,300 +13,050	+209%	+$1.11M	0.07%	280
2018 Q4	$448K	Hold	6,250	–	–	0.02%	563
2018 Q3	$599K	Hold	6,250	–	–	0.02%	620
2018 Q2	$595K	Hold	6,250	–	–	0.02%	622
2018 Q1	$548K	Sell	6,250 -1,750	-22%	-$160K	0.02%	602
2017 Q4	$679K	Buy	+8,000	New	+$670K	0.02%	678
2017 Q1	–	Sell	-20,125	Closed	-$1.19M	–	1097
2016 Q4	$1.19M	Buy	+20,125	New	+$1.24M	0.02%	589

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

GAM Holding's XBI Position: Q1 2020 in Review

GAM Holding sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 18,800 shares — an estimated $1.79M sold.

GAM Holding first reported a position in XBI in Q4 2016 and held it in 10 quarters. The position peaked at $1.79M in Q4 2019. 458 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

GAM Holding reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
GAM Holding sold 18,800 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $1.79M.
GAM Holding first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 10 quarters.
GAM Holding's State Street SPDR S&P Biotech ETF position peaked at $1.79M in Q4 2019.
458 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on GAM Holding's 13F filing for Q1 2020, filed 12 May 2020.